Global Live Brucellosis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 136

Published Date: 13 Dec 2024

Category: Agriculture

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Live Brucellosis Vaccine market size was valued at US$ 194 million in 2023 and is forecast to a readjusted size of USD 253 million by 2030 with a CAGR of 4.1% during review period.

Live Brucellosis Vaccine is a kind of vaccine used to prevent brucellosis, which is also known as Malta fever or undulant fever. It is a live attenuated vaccine prepared from weakened strains of Brucella bacteria. The attenuated Brucella strains in the live vaccine still retain certain antigenicity, which can stimulate the body's immune system to produce a relatively strong immune response, inducing the production of specific antibodies and cell-mediated immune responses, thereby providing effective protection for the body to prevent the occurrence of brucellosis. The attenuated strains in the live vaccine can replicate to a limited extent in the body, allowing the body's immune system to be continuously stimulated by antigens, resulting in more long-lasting immunity and extending the duration of immune protection.

This report is a detailed and comprehensive analysis for global Live Brucellosis Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Live Brucellosis Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Live Brucellosis Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Live Brucellosis Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Live Brucellosis Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Live Brucellosis Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Live Brucellosis Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CZ Vaccines, MSD, Ceva, Colorado Serum, Tecnovax, Syva, Shchelkovo Biocombinat, Jinyu Baoling, Biovet, CAVAC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Live Brucellosis Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Strain RB-51
    Strain S19
    Strain S2
    Strain A19
    Strain Rev. I

Market segment by Application
    Cattle
    Sheep
    Pig
    Others

Major players covered
    CZ Vaccines
    MSD
    Ceva
    Colorado Serum
    Tecnovax
    Syva
    Shchelkovo Biocombinat
    Jinyu Baoling
    Biovet
    CAVAC
    VETAL
    Indian Immunologicals
    Dollvet
    Hester Biosciences
    Qilu Animal Health
    Auleon Biologicals

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Live Brucellosis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live Brucellosis Vaccine, with price, sales quantity, revenue, and global market share of Live Brucellosis Vaccine from 2019 to 2024.
Chapter 3, the Live Brucellosis Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Brucellosis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Live Brucellosis Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live Brucellosis Vaccine.
Chapter 14 and 15, to describe Live Brucellosis Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Live Brucellosis Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Strain RB-51
        1.3.3 Strain S19
        1.3.4 Strain S2
        1.3.5 Strain A19
        1.3.6 Strain Rev. I
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Live Brucellosis Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Cattle
        1.4.3 Sheep
        1.4.4 Pig
        1.4.5 Others
    1.5 Global Live Brucellosis Vaccine Market Size & Forecast
        1.5.1 Global Live Brucellosis Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Live Brucellosis Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Live Brucellosis Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 CZ Vaccines
        2.1.1 CZ Vaccines Details
        2.1.2 CZ Vaccines Major Business
        2.1.3 CZ Vaccines Live Brucellosis Vaccine Product and Services
        2.1.4 CZ Vaccines Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 CZ Vaccines Recent Developments/Updates
    2.2 MSD
        2.2.1 MSD Details
        2.2.2 MSD Major Business
        2.2.3 MSD Live Brucellosis Vaccine Product and Services
        2.2.4 MSD Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 MSD Recent Developments/Updates
    2.3 Ceva
        2.3.1 Ceva Details
        2.3.2 Ceva Major Business
        2.3.3 Ceva Live Brucellosis Vaccine Product and Services
        2.3.4 Ceva Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Ceva Recent Developments/Updates
    2.4 Colorado Serum
        2.4.1 Colorado Serum Details
        2.4.2 Colorado Serum Major Business
        2.4.3 Colorado Serum Live Brucellosis Vaccine Product and Services
        2.4.4 Colorado Serum Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Colorado Serum Recent Developments/Updates
    2.5 Tecnovax
        2.5.1 Tecnovax Details
        2.5.2 Tecnovax Major Business
        2.5.3 Tecnovax Live Brucellosis Vaccine Product and Services
        2.5.4 Tecnovax Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Tecnovax Recent Developments/Updates
    2.6 Syva
        2.6.1 Syva Details
        2.6.2 Syva Major Business
        2.6.3 Syva Live Brucellosis Vaccine Product and Services
        2.6.4 Syva Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Syva Recent Developments/Updates
    2.7 Shchelkovo Biocombinat
        2.7.1 Shchelkovo Biocombinat Details
        2.7.2 Shchelkovo Biocombinat Major Business
        2.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Product and Services
        2.7.4 Shchelkovo Biocombinat Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Shchelkovo Biocombinat Recent Developments/Updates
    2.8 Jinyu Baoling
        2.8.1 Jinyu Baoling Details
        2.8.2 Jinyu Baoling Major Business
        2.8.3 Jinyu Baoling Live Brucellosis Vaccine Product and Services
        2.8.4 Jinyu Baoling Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Jinyu Baoling Recent Developments/Updates
    2.9 Biovet
        2.9.1 Biovet Details
        2.9.2 Biovet Major Business
        2.9.3 Biovet Live Brucellosis Vaccine Product and Services
        2.9.4 Biovet Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Biovet Recent Developments/Updates
    2.10 CAVAC
        2.10.1 CAVAC Details
        2.10.2 CAVAC Major Business
        2.10.3 CAVAC Live Brucellosis Vaccine Product and Services
        2.10.4 CAVAC Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 CAVAC Recent Developments/Updates
    2.11 VETAL
        2.11.1 VETAL Details
        2.11.2 VETAL Major Business
        2.11.3 VETAL Live Brucellosis Vaccine Product and Services
        2.11.4 VETAL Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 VETAL Recent Developments/Updates
    2.12 Indian Immunologicals
        2.12.1 Indian Immunologicals Details
        2.12.2 Indian Immunologicals Major Business
        2.12.3 Indian Immunologicals Live Brucellosis Vaccine Product and Services
        2.12.4 Indian Immunologicals Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Indian Immunologicals Recent Developments/Updates
    2.13 Dollvet
        2.13.1 Dollvet Details
        2.13.2 Dollvet Major Business
        2.13.3 Dollvet Live Brucellosis Vaccine Product and Services
        2.13.4 Dollvet Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Dollvet Recent Developments/Updates
    2.14 Hester Biosciences
        2.14.1 Hester Biosciences Details
        2.14.2 Hester Biosciences Major Business
        2.14.3 Hester Biosciences Live Brucellosis Vaccine Product and Services
        2.14.4 Hester Biosciences Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Hester Biosciences Recent Developments/Updates
    2.15 Qilu Animal Health
        2.15.1 Qilu Animal Health Details
        2.15.2 Qilu Animal Health Major Business
        2.15.3 Qilu Animal Health Live Brucellosis Vaccine Product and Services
        2.15.4 Qilu Animal Health Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Qilu Animal Health Recent Developments/Updates
    2.16 Auleon Biologicals
        2.16.1 Auleon Biologicals Details
        2.16.2 Auleon Biologicals Major Business
        2.16.3 Auleon Biologicals Live Brucellosis Vaccine Product and Services
        2.16.4 Auleon Biologicals Live Brucellosis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Auleon Biologicals Recent Developments/Updates

3 Competitive Environment: Live Brucellosis Vaccine by Manufacturer
    3.1 Global Live Brucellosis Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Live Brucellosis Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Live Brucellosis Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Live Brucellosis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Live Brucellosis Vaccine Manufacturer Market Share in 2023
        3.4.3 Top 6 Live Brucellosis Vaccine Manufacturer Market Share in 2023
    3.5 Live Brucellosis Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Live Brucellosis Vaccine Market: Region Footprint
        3.5.2 Live Brucellosis Vaccine Market: Company Product Type Footprint
        3.5.3 Live Brucellosis Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Live Brucellosis Vaccine Market Size by Region
        4.1.1 Global Live Brucellosis Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Live Brucellosis Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Live Brucellosis Vaccine Average Price by Region (2019-2030)
    4.2 North America Live Brucellosis Vaccine Consumption Value (2019-2030)
    4.3 Europe Live Brucellosis Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Live Brucellosis Vaccine Consumption Value (2019-2030)
    4.5 South America Live Brucellosis Vaccine Consumption Value (2019-2030)
    4.6 Middle East & Africa Live Brucellosis Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Live Brucellosis Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Live Brucellosis Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Live Brucellosis Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Live Brucellosis Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Live Brucellosis Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Live Brucellosis Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Live Brucellosis Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Live Brucellosis Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Live Brucellosis Vaccine Market Size by Country
        7.3.1 North America Live Brucellosis Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Live Brucellosis Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Live Brucellosis Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Live Brucellosis Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Live Brucellosis Vaccine Market Size by Country
        8.3.1 Europe Live Brucellosis Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Live Brucellosis Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Live Brucellosis Vaccine Market Size by Region
        9.3.1 Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Live Brucellosis Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Live Brucellosis Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Live Brucellosis Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Live Brucellosis Vaccine Market Size by Country
        10.3.1 South America Live Brucellosis Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Live Brucellosis Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Live Brucellosis Vaccine Market Size by Country
        11.3.1 Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Live Brucellosis Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Live Brucellosis Vaccine Market Drivers
    12.2 Live Brucellosis Vaccine Market Restraints
    12.3 Live Brucellosis Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Live Brucellosis Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Live Brucellosis Vaccine
    13.3 Live Brucellosis Vaccine Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Live Brucellosis Vaccine Typical Distributors
    14.3 Live Brucellosis Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Live Brucellosis Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Live Brucellosis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. CZ Vaccines Basic Information, Manufacturing Base and Competitors
 Table 4. CZ Vaccines Major Business
 Table 5. CZ Vaccines Live Brucellosis Vaccine Product and Services
 Table 6. CZ Vaccines Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. CZ Vaccines Recent Developments/Updates
 Table 8. MSD Basic Information, Manufacturing Base and Competitors
 Table 9. MSD Major Business
 Table 10. MSD Live Brucellosis Vaccine Product and Services
 Table 11. MSD Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. MSD Recent Developments/Updates
 Table 13. Ceva Basic Information, Manufacturing Base and Competitors
 Table 14. Ceva Major Business
 Table 15. Ceva Live Brucellosis Vaccine Product and Services
 Table 16. Ceva Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Ceva Recent Developments/Updates
 Table 18. Colorado Serum Basic Information, Manufacturing Base and Competitors
 Table 19. Colorado Serum Major Business
 Table 20. Colorado Serum Live Brucellosis Vaccine Product and Services
 Table 21. Colorado Serum Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Colorado Serum Recent Developments/Updates
 Table 23. Tecnovax Basic Information, Manufacturing Base and Competitors
 Table 24. Tecnovax Major Business
 Table 25. Tecnovax Live Brucellosis Vaccine Product and Services
 Table 26. Tecnovax Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Tecnovax Recent Developments/Updates
 Table 28. Syva Basic Information, Manufacturing Base and Competitors
 Table 29. Syva Major Business
 Table 30. Syva Live Brucellosis Vaccine Product and Services
 Table 31. Syva Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Syva Recent Developments/Updates
 Table 33. Shchelkovo Biocombinat Basic Information, Manufacturing Base and Competitors
 Table 34. Shchelkovo Biocombinat Major Business
 Table 35. Shchelkovo Biocombinat Live Brucellosis Vaccine Product and Services
 Table 36. Shchelkovo Biocombinat Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Shchelkovo Biocombinat Recent Developments/Updates
 Table 38. Jinyu Baoling Basic Information, Manufacturing Base and Competitors
 Table 39. Jinyu Baoling Major Business
 Table 40. Jinyu Baoling Live Brucellosis Vaccine Product and Services
 Table 41. Jinyu Baoling Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Jinyu Baoling Recent Developments/Updates
 Table 43. Biovet Basic Information, Manufacturing Base and Competitors
 Table 44. Biovet Major Business
 Table 45. Biovet Live Brucellosis Vaccine Product and Services
 Table 46. Biovet Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Biovet Recent Developments/Updates
 Table 48. CAVAC Basic Information, Manufacturing Base and Competitors
 Table 49. CAVAC Major Business
 Table 50. CAVAC Live Brucellosis Vaccine Product and Services
 Table 51. CAVAC Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. CAVAC Recent Developments/Updates
 Table 53. VETAL Basic Information, Manufacturing Base and Competitors
 Table 54. VETAL Major Business
 Table 55. VETAL Live Brucellosis Vaccine Product and Services
 Table 56. VETAL Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. VETAL Recent Developments/Updates
 Table 58. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
 Table 59. Indian Immunologicals Major Business
 Table 60. Indian Immunologicals Live Brucellosis Vaccine Product and Services
 Table 61. Indian Immunologicals Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. Indian Immunologicals Recent Developments/Updates
 Table 63. Dollvet Basic Information, Manufacturing Base and Competitors
 Table 64. Dollvet Major Business
 Table 65. Dollvet Live Brucellosis Vaccine Product and Services
 Table 66. Dollvet Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 67. Dollvet Recent Developments/Updates
 Table 68. Hester Biosciences Basic Information, Manufacturing Base and Competitors
 Table 69. Hester Biosciences Major Business
 Table 70. Hester Biosciences Live Brucellosis Vaccine Product and Services
 Table 71. Hester Biosciences Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 72. Hester Biosciences Recent Developments/Updates
 Table 73. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
 Table 74. Qilu Animal Health Major Business
 Table 75. Qilu Animal Health Live Brucellosis Vaccine Product and Services
 Table 76. Qilu Animal Health Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Qilu Animal Health Recent Developments/Updates
 Table 78. Auleon Biologicals Basic Information, Manufacturing Base and Competitors
 Table 79. Auleon Biologicals Major Business
 Table 80. Auleon Biologicals Live Brucellosis Vaccine Product and Services
 Table 81. Auleon Biologicals Live Brucellosis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 82. Auleon Biologicals Recent Developments/Updates
 Table 83. Global Live Brucellosis Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 84. Global Live Brucellosis Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 85. Global Live Brucellosis Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 86. Market Position of Manufacturers in Live Brucellosis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 87. Head Office and Live Brucellosis Vaccine Production Site of Key Manufacturer
 Table 88. Live Brucellosis Vaccine Market: Company Product Type Footprint
 Table 89. Live Brucellosis Vaccine Market: Company Product Application Footprint
 Table 90. Live Brucellosis Vaccine New Market Entrants and Barriers to Market Entry
 Table 91. Live Brucellosis Vaccine Mergers, Acquisition, Agreements, and Collaborations
 Table 92. Global Live Brucellosis Vaccine Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 93. Global Live Brucellosis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
 Table 94. Global Live Brucellosis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
 Table 95. Global Live Brucellosis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
 Table 96. Global Live Brucellosis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
 Table 97. Global Live Brucellosis Vaccine Average Price by Region (2019-2024) & (US$/Unit)
 Table 98. Global Live Brucellosis Vaccine Average Price by Region (2025-2030) & (US$/Unit)
 Table 99. Global Live Brucellosis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 100. Global Live Brucellosis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 101. Global Live Brucellosis Vaccine Consumption Value by Type (2019-2024) & (USD Million)
 Table 102. Global Live Brucellosis Vaccine Consumption Value by Type (2025-2030) & (USD Million)
 Table 103. Global Live Brucellosis Vaccine Average Price by Type (2019-2024) & (US$/Unit)
 Table 104. Global Live Brucellosis Vaccine Average Price by Type (2025-2030) & (US$/Unit)
 Table 105. Global Live Brucellosis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 106. Global Live Brucellosis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 107. Global Live Brucellosis Vaccine Consumption Value by Application (2019-2024) & (USD Million)
 Table 108. Global Live Brucellosis Vaccine Consumption Value by Application (2025-2030) & (USD Million)
 Table 109. Global Live Brucellosis Vaccine Average Price by Application (2019-2024) & (US$/Unit)
 Table 110. Global Live Brucellosis Vaccine Average Price by Application (2025-2030) & (US$/Unit)
 Table 111. North America Live Brucellosis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 112. North America Live Brucellosis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 113. North America Live Brucellosis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 114. North America Live Brucellosis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 115. North America Live Brucellosis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 116. North America Live Brucellosis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 117. North America Live Brucellosis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 118. North America Live Brucellosis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 119. Europe Live Brucellosis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 120. Europe Live Brucellosis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 121. Europe Live Brucellosis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 122. Europe Live Brucellosis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 123. Europe Live Brucellosis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 124. Europe Live Brucellosis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 125. Europe Live Brucellosis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 126. Europe Live Brucellosis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 127. Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 128. Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 129. Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 130. Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 131. Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
 Table 132. Asia-Pacific Live Brucellosis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
 Table 133. Asia-Pacific Live Brucellosis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
 Table 134. Asia-Pacific Live Brucellosis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
 Table 135. South America Live Brucellosis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 136. South America Live Brucellosis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 137. South America Live Brucellosis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 138. South America Live Brucellosis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 139. South America Live Brucellosis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 140. South America Live Brucellosis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 141. South America Live Brucellosis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 142. South America Live Brucellosis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 143. Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 144. Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 145. Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 146. Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 147. Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 148. Middle East & Africa Live Brucellosis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 149. Middle East & Africa Live Brucellosis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 150. Middle East & Africa Live Brucellosis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 151. Live Brucellosis Vaccine Raw Material
 Table 152. Key Manufacturers of Live Brucellosis Vaccine Raw Materials
 Table 153. Live Brucellosis Vaccine Typical Distributors
 Table 154. Live Brucellosis Vaccine Typical Customers


List of Figures
 Figure 1. Live Brucellosis Vaccine Picture
 Figure 2. Global Live Brucellosis Vaccine Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Live Brucellosis Vaccine Revenue Market Share by Type in 2023
 Figure 4. Strain RB-51 Examples
 Figure 5. Strain S19 Examples
 Figure 6. Strain S2 Examples
 Figure 7. Strain A19 Examples
 Figure 8. Strain Rev. I Examples
 Figure 9. Global Live Brucellosis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 10. Global Live Brucellosis Vaccine Revenue Market Share by Application in 2023
 Figure 11. Cattle Examples
 Figure 12. Sheep Examples
 Figure 13. Pig Examples
 Figure 14. Others Examples
 Figure 15. Global Live Brucellosis Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 16. Global Live Brucellosis Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 17. Global Live Brucellosis Vaccine Sales Quantity (2019-2030) & (K Units)
 Figure 18. Global Live Brucellosis Vaccine Price (2019-2030) & (US$/Unit)
 Figure 19. Global Live Brucellosis Vaccine Sales Quantity Market Share by Manufacturer in 2023
 Figure 20. Global Live Brucellosis Vaccine Revenue Market Share by Manufacturer in 2023
 Figure 21. Producer Shipments of Live Brucellosis Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 22. Top 3 Live Brucellosis Vaccine Manufacturer (Revenue) Market Share in 2023
 Figure 23. Top 6 Live Brucellosis Vaccine Manufacturer (Revenue) Market Share in 2023
 Figure 24. Global Live Brucellosis Vaccine Sales Quantity Market Share by Region (2019-2030)
 Figure 25. Global Live Brucellosis Vaccine Consumption Value Market Share by Region (2019-2030)
 Figure 26. North America Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 27. Europe Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 28. Asia-Pacific Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 29. South America Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 30. Middle East & Africa Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 31. Global Live Brucellosis Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 32. Global Live Brucellosis Vaccine Consumption Value Market Share by Type (2019-2030)
 Figure 33. Global Live Brucellosis Vaccine Average Price by Type (2019-2030) & (US$/Unit)
 Figure 34. Global Live Brucellosis Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 35. Global Live Brucellosis Vaccine Revenue Market Share by Application (2019-2030)
 Figure 36. Global Live Brucellosis Vaccine Average Price by Application (2019-2030) & (US$/Unit)
 Figure 37. North America Live Brucellosis Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 38. North America Live Brucellosis Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 39. North America Live Brucellosis Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 40. North America Live Brucellosis Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 41. United States Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 42. Canada Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 43. Mexico Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 44. Europe Live Brucellosis Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 45. Europe Live Brucellosis Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 46. Europe Live Brucellosis Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 47. Europe Live Brucellosis Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 48. Germany Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 49. France Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 50. United Kingdom Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 51. Russia Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 52. Italy Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 53. Asia-Pacific Live Brucellosis Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 54. Asia-Pacific Live Brucellosis Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 55. Asia-Pacific Live Brucellosis Vaccine Sales Quantity Market Share by Region (2019-2030)
 Figure 56. Asia-Pacific Live Brucellosis Vaccine Consumption Value Market Share by Region (2019-2030)
 Figure 57. China Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 58. Japan Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 59. South Korea Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 60. India Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 61. Southeast Asia Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 62. Australia Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 63. South America Live Brucellosis Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 64. South America Live Brucellosis Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 65. South America Live Brucellosis Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 66. South America Live Brucellosis Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 67. Brazil Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 68. Argentina Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 69. Middle East & Africa Live Brucellosis Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 70. Middle East & Africa Live Brucellosis Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 71. Middle East & Africa Live Brucellosis Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 72. Middle East & Africa Live Brucellosis Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 73. Turkey Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 74. Egypt Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 75. Saudi Arabia Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 76. South Africa Live Brucellosis Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 77. Live Brucellosis Vaccine Market Drivers
 Figure 78. Live Brucellosis Vaccine Market Restraints
 Figure 79. Live Brucellosis Vaccine Market Trends
 Figure 80. Porters Five Forces Analysis
 Figure 81. Manufacturing Cost Structure Analysis of Live Brucellosis Vaccine in 2023
 Figure 82. Manufacturing Process Analysis of Live Brucellosis Vaccine
 Figure 83. Live Brucellosis Vaccine Industrial Chain
 Figure 84. Sales Channel: Direct to End-User vs Distributors
 Figure 85. Direct Channel Pros & Cons
 Figure 86. Indirect Channel Pros & Cons
 Figure 87. Methodology
 Figure 88. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CZ Vaccines
MSD
Ceva
Colorado Serum
Tecnovax
Syva
Shchelkovo Biocombinat
Jinyu Baoling
Biovet
CAVAC
VETAL
Indian Immunologicals
Dollvet
Hester Biosciences
Qilu Animal Health
Auleon Biologicals

Related Reports

Global Live Brucellosis Vaccine Supply, Demand and Key Producers, 2024-2030

Global Live Brucellosis Vaccine Supply, Demand and Key Producers, 2024-2030

date 13 Dec 2024

date Agriculture

The global Live Brucellosis Vaccine market size is expected to reach $ 253 million by 2030, rising at a market growth of 4.1% CAGR during the forecast period (2024-2030).

Product Tags

Live Brucellosis Vaccine

Ornamental Freshwater Fish

Polyamide 613 Powder

Brassica Seed

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>